Elevance Health Inc. (ELV) is currently Undervalued by 26.59%

Elevance Health Inc. (ELV) appears undervalued by approximately 26.59% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

Upside (live) 26.59% (from live valuation API)
Confidence (live) 6.5/10 (Moderate)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$417.89

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE Calculator Stock Valuation Calculator

Why is Elevance Health Inc. overvalued or undervalued?

For Elevance Health Inc., intrinsic value ties fair value to sustainable cash generation; with the stock above that level, the snapshot reads as a premium versus fundamentals rather than a pure sentiment call.

Historical valuation for ELV shows cycles where multiples expanded and compressed; today’s positioning rhymes more with growth optimism than the mid-range of its recent history.

Market expectations boil down to growth, risk, and return on capital—current levels bake in strong execution, so disappointments hit harder. Cross-check with live ratios when your API is connected.

Key metrics

P/E ratio: 43.8x
Revenue growth (TTM y/y): 18%
Profit margin: 24.4%
Fair value (model): Unlock

Next steps

Frequently asked questions — ELV

Is ELV overvalued right now?

A stock is overvalued when its market price sits above a reasonable fair value range. Use the live snapshot on this page for ELV, then validate with fundamentals and peer multiples.

What is Elevance Health Inc.'s intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether ELV trades above or below fair value. At $417.89, Elevance Health Inc. currently looks undervalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Elevance Health Inc.'s intrinsic value calculated?

Tickerplace calculates ELV's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is ELV undervalued right now?

Based on our 2026 valuation models, Elevance Health Inc. (ELV) appears undervalued at $417.89 with about 26.6% upside to fair value. Treat this as a screen—verify fundamentals on the company profile.

Peers for ELV: open their overvalued / undervalued view.

Instant valuation answer